Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Two series of kinase/phosphatase inhibitors and their use in cancer and cardiovascular disorders

March 1, 2004

Hollis-Eden acquires Congressional Pharmaceutical

March 1, 2004

Diatos secures financing to advance development of DTS-201

March 1, 2004

OSI expands ongoing phase I study of OSI-461

March 1, 2004

Callisto acquires rights to novel cancer technology platform

March 1, 2004

Promising preclinical results with Vertex's Aurora kinase inhibitor VX-680

March 1, 2004

Gabapentin found effective against tamoxifen-related hot flashes in breast cancer

March 1, 2004

Orphan drug designation for CG-53135

Feb. 27, 2004

Mitsui Chemicals claims telomerase inhibitors for cancer and other uses

Feb. 27, 2004

Neoprobe to meet FDA concerning RIGScan CR49 BLA

Feb. 27, 2004

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...